Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Flubio Vaccine in Infants and Children
NCT02093260Phase 3Completed
- Sponsor
- Bio Farma
- Start
- May 2014
- Primary completion
- Jul 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus vaccine (Flubio) in influenza, sponsored by Bio Farma. Started May 2014; status: completed.
02
Drugs
influenza virus vaccine (Flubio)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02093260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093260.